US 11278619
DNA antibody constructs and method of using same
granted A61KA61K2039/505A61K2039/53
Quick answer
US patent 11278619 (DNA antibody constructs and method of using same) held by Inovio Pharmaceuticals, Inc. expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K2039/53, A61K39/39558, A61K48/0016